USV
Location
India
Description
USV offers R&D and manufacturing capabilities in APIs and intermediates in finished dosage forms and is recognized as the world’s leading producer of metformin HCl.
FDA Status
FDA Inspected
Therapeutic Classes
APIs: anti-diabetes, cardiovascular, oncology, CNS and ophthalmology.Finished Dosage: anti-diabetes, cardiovascular and nutritional.
Facilities / Capabilities
R&D capabilities include lab scale, kilo for producing quantities from 1 to 5 kilos and pilot plant facility for producing quantities from 5 to 25 kilos. Pilot plant has 21 reactors with capacities ranging from 100 liters to 1,600 liters with both SS and glass reactors. A separate area is being created for specialty products.
Manufacturing
APIs: Dedicated facilities for metformin and glipizide. Dedicated equipment for glyburide. Multipurpose manufacturing facility for APIs.Finished Dosage: Has a newly built finished dosage facility designed to meet FDA standards and approved by European authorities for oral solid dosage.
http://www.usvindia.com